CDK4 and neoplasm: In this regard, inhibition of CDK4/6 in cancer cells reduces the levels of the anti-oxidants NADPH and glutathione [9], stabilizes the immunosuppressive ligand PD-L1 (ref. [10]), stimulates tumor antigen presentation [10], and hyperactivates proteasomal function [11].